Press Releases from Exactitude Consultancy (18173 total)
Market is expected to grow at USD 300 million by 2034, Driven by 7.5% CAGR
" The global COMP ELISA kit market is valued at approximately $150 million in 2024, driven by increased research and diagnostic applications in clinical settings.…
VDAC1 Antibody Market is estimated to expand at USD 480 million by 2034, driven …
" The VDAC1 antibody market is poised for significant growth, anticipated to reach a value of approximately $220 million in 2024. Projections suggest that the…
Anti-Neuropilin-1 Antibody Market is expected to reach USD 1.2 billion by 2034, …
" As of 2024, the global Anti-Neuropilin-1 Antibody market is valued at approximately $450 million. The projected market value is expected to reach around $1.2…
RdRp Inhibitor Market is estimated to reach USD 6.4 billion by 2034, expanding a …
" The RNA-dependent RNA polymerase (RdRp) inhibitor market is projected to reach a value of approximately $2.5 billion in 2024, bolstered by increasing demand for…
Granzyme H Antibody Market is expected to reach USD 600 million by 2034
" The Granzyme H antibody market is currently valued at approximately $250 million in 2024, driven by increasing research and development in immunotherapy and advancements…
Cytochrome C Antibody Market is expected to grow at USD 350 million by 2034
" The global Cytochrome C Antibody market is valued at approximately $210 million in 2024, driven by increasing research activities in cell apoptosis and related…
Alpha-fetoprotein Antibody Market is estimated to expand at USD billion by 2034, …
" The global Alpha-fetoprotein (AFP) antibody market is valued at approximately $1.5 billion in 2024, with prospects to reach around $3 billion by 2034. This…
Huoxiang Zhengqi Drug Market is expected to reach USD 2.5 billion by 2034, growi …
" The Huoxiang Zhengqi Drug market is projected to reach approximately $1.2 billion in 2024, driven by the growing demand for traditional Chinese medicine (TCM)…
Antisense Oligonucleotides (ASO) Drug Market is estimated to reach USD 12.3 bill …
" The global Antisense Oligonucleotides (ASO) drug market is projected to reach approximately $5.8 billion in 2024, driven by increasing applications in molecular therapeutics and…
PDGFA Antibody Market is expected to reach USD 3.2 billion by 2034, growing at a …
" The PDGFA antibody market is projected to reach a value of approximately $1.5 billion in 2024, driven by increasing research funding and the expanding…
AMPK Antibody Market is expected to grow at USD 2.5 billion by 2034
" In 2024, the AMPK antibody market is valued at approximately $1.2 billion, fueled by the growing demand for research products in metabolic diseases and…
DLL4 ELISA Kit Market is expected to reach USD 300 million by 2034, growing at a …
The global DLL4 ELISA Kit market is estimated to be valued at approximately $150 million in 2024. This market is projected to reach around $300…
TLR3 Antibody Market is estimated to expand at USD 3.2 billion by 2034, driven b …
" The TLR3 antibody market is anticipated to reach a value of approximately $1.5 billion by the end of 2024, driven by increasing research activities…
Leukocyte Surface Antigen CD47 Antibody Market to Reach USD 6 Billion by 2034, G …
As of 2024, the global market for Leukocyte Surface Antigen CD47 Antibody is valued at approximately $2.5 billion, driven by increased research funding, heightened awareness…
OX40 Antibody Market is estimated to reach USD 4.5 billion by 2034, expanding at …
" The global OX40 antibody market is valued at approximately $1.5 billion in 2024, driven by increasing investments in immunotherapy and advancements in cancer treatment…
TDO2 Antibody Market is expected to reach USD 2.8 billion by 2034, growing at a …
" The global TDO2 antibody market is projected to reach approximately $1.2 billion by the end of 2024, driven by increasing investments in cancer immunotherapy…
Real-Time Fluorescent qPCR and Digital PCR Market is expected to reach $7.2 bill …
The global market for real-time fluorescent quantitative PCR (qPCR) and digital PCR (dPCR) is projected to reach approximately $4.3 billion in 2024, with expectations of…
Aurora Kinase B Antibody Market is expected to grow at USD 2.4 billion by 2034, …
" The global market for Aurora Kinase B antibodies is anticipated to reach approximately USD 1.2 billion in 2024, driven by the increasing prevalence of…
DLL4 Antibody Market is estimated to expand at USD 5.4 billion by 2034, driven b …
" The global DLL4 antibody market is valued at approximately $2.1 billion in 2024, with projections indicating growth to around $5.4 billion by 2034. This…
HER2 Antibody Market is expected to reach USD 42 billion by 2034, growing at a 5 …
The global HER2 (Human Epidermal Growth Factor Receptor 2) antibody market is valued at approximately $25 billion in 2024, with expectations to reach around $42…
CD48 Antibody Market to Grow to USD 3.2 Billion by 2034, Driven by 9% CAGR on Ri …
The CD48 antibody market, valued at approximately $1.3 billion in 2024, is projected to reach $3.2 billion by 2034, reflecting a robust CAGR of 9%…
FGFR2 Antibody Market is expected to reach USD 2.5 billion by 2034, growing at a …
The FGFR2 antibody market is valued at approximately $1.2 billion in 2024, driven by the increasing prevalence of cancers associated with fibroblast growth factor receptors.…
Flt-3 Antibody Market is expected to reach USD 2.8 billion by 2034, growing at a …
" The global Flt-3 antibody market is valued at approximately $1.2 billion in 2024, with projections indicating robust growth, reaching around $2.8 billion by 2034.…
Real-time Fluorescent Quantitative PCR Kit Market is estimated to reach USD 2.8 …
" The real-time fluorescent quantitative PCR (qPCR) kit market is valued at approximately $1.5 billion in 2024, driven by increasing demand for accurate and rapid…
CD20 Antibody Market is expected to reach USD 24 billion by 2034, with a 9% CAGR
The global CD20 antibody market is valued at approximately $10 billion in 2024, and it is projected to reach around $24 billion by 2034, indicating…
Hepatocyte Growth Factor (HGF) Antibody Market is expected to reach USD 2.5 bill …
" The Hepatocyte Growth Factor (HGF) antibody market is experiencing notable growth, with an estimated market value of approximately $1.2 billion in 2024. Projections indicate…
gpA33 Antibody Market to Grow to USD 1.2 Billion by 2034 at an 8.5% CAGR
The gpA33 antibody market is projected to reach approximately $550 million in 2024, driven by increasing applications in cancer immunotherapy and diagnostics. Within the forecast…
Galectin-9 Antibody Market is expected to grow at USD 560 million by 2034, Drive …
" The global Galectin-9 antibody market is valued at approximately $200 million in 2024 and is projected to reach around $560 million by 2034, reflecting…
CD33 Antibody Market to Reach USD 3.5 Billion by 2034, Expanding at 9.1% CAGR
The CD33 antibody market is projected to reach a value of approximately $1.5 billion in 2024, driven by growing awareness and advancements in therapeutic applications…
DNAM-1 Antibody Market is estimated to expand at USD 3.5 billion by 2034, driven …
" The DNAM-1 antibody market is poised for significant growth, with a current market value estimated at approximately $1.2 billion in 2024. Forecasts suggest the…
B7-1 Antibody Market to Reach USD 4.5 Billion by 2034, Growing at an 8.0% CAGR a …
The global B7-1 antibody market is valued at approximately $2.1 billion in 2024 and is projected to reach $4.5 billion by 2034. This growth reflects…
EpCAM Antibody Market is expected to reach USD 2.5 billion by 2034, growing at a …
" The global EpCAM antibody market is valued at approximately $1.2 billion in 2024 and is projected to reach around $2.5 billion by 2034, reflecting…
CDK6 Antibodies Market to Reach $2.5 Billion by 2034, Growing at 8.5% CAGR
The global market for CDK6 antibodies is projected to reach approximately $1.2 billion in 2024, driven by increasing research activities in oncology and the rising…
T Cell-specific Surface Glycoprotein CD28 Antibody Market is estimated to reach …
" The global market for T Cell-specific Surface Glycoprotein CD28 Antibodies is valued at approximately $1.5 billion in 2024. It is projected to grow significantly,…
BTLA Antibody Market is expected to reach USD 4.3 billion by 2034, growing at a …
The global BTLA (B and T Lymphocyte Attenuator) antibody market is estimated to reach a value of approximately $1.5 billion in 2024, driven by increasing…
Aurora Kinases Antibody Market to Surpass USD 1.2 Billion by 2034, Growing at 9. …
As of 2024, the worldwide Aurora Kinases The antibody industry is worth roughly USD 500 million, driven by rising cancer rates and advances in…
TRAIL Antibody Market to Reach $5.7 Billion by 2034, Driven by a 9.4% CAGR
The TRAIL antibody market is poised for significant growth, currently valued at approximately $2.3 billion in 2024. Projections indicate a robust increase to around $5.7…
FGFR5 Antibody Market is expected to reach USD 2.5 billion by 2034, growing at a …
" The FGFR5 antibody market was valued at approximately $1.2 billion in 2024, driven by increasing demand for targeted therapies and advancements in monoclonal antibody…
RET Antibody Market is expected to surpass $12 billion by 2034, with an 8.5% CAG …
The global RET antibody market, valued at approximately $5.2 billion in 2024, is anticipated to expand significantly, with a projected market value of around $12.1…
PIK3CB antibody Market is expected to reach USD 2.5 billion by 2034, growing at …
The global PIK3CB antibody market is poised to reach an estimated value of $1.2 billion in 2024, driven by the increasing prevalence of cancer and…
MUC1 Antibody Market to Triple by 2034, Surging to $3.6 Billion at 12.3% CAGR
The MUC1 antibody market is poised for significant growth, currently valued at approximately $1.2 billion in 2024. Projections indicate a substantial increase, with an anticipated…
Light Antibody Market is expected to reach USD 52 billion by 2034, driven by a 5 …
The global light antibody market is valued at approximately $32 billion in 2024, driven by increasing demand for targeted therapies in oncology and autoimmune diseases.…
Immunomagnetic Beads Protein Market is expected to grow at USD 2.5 billion by 20 …
" The global market for immunomagnetic beads, valued at approximately $1.2 billion in 2024, is poised for significant expansion, with projections suggesting it will reach…
ICOS Antibody Market to Double by 2034, Reaching USD 9 Billion at 7.3% CAGR Grow …
The global ICOS antibody market is valued at approximately $4.5 billion in 2024 and is expected to reach around $9 billion by 2034, reflecting a…
FGFR1 Antibody Market is expected to reach USD 2.5 billion by 2034, growing at a …
The global FGFR1 antibody market is projected to reach a value of approximately $1.2 billion in 2024, driven by rising demands in oncology and precision…
Threonine Protein Kinase Chk1 Antibody Market is estimated to expand at USD 500 …
" The market for Threonine Protein Kinase Chk1 Antibodies is poised for significant growth, with a projected market value of approximately $250 million by 2024.…
CEACAM1 Antibody Market to Exceed $1 Billion by 2034, Propelled by Strong 15% CA …
The CEACAM1 antibody market is estimated to reach a value of approximately $250 million in 2024, driven by increasing research and therapeutic applications, particularly in…
CD155 Antibody Market is expected to reach USD 5.4 billion by 2034, growing at a …
" As of 2024, the global CD155 antibody market is valued at approximately $2.1 billion, driven by the expanding application of immunotherapies and increasing research…
Bcr-Abl Antibody Market is estimated to reach USD 4.1 billion by 2034, expanding …
" The Bcr-Abl antibody market is valued at approximately $2.15 billion in 2024 and is projected to reach around $4.1 billion by 2034, reflecting a…
VISTA Antibody Market is expected to reach USD 3.5 billion by 2034, growing at a …
" The global VISTA antibody market is expected to reach approximately $1.2 billion in value by 2024, driven primarily by increasing adoption in cancer immunotherapy…
